SCTSC Versus Trabeculectomy in Medically Uncontrolled Open-Angle Glaucoma in Pseudophakic Patients

ConditionGlaucoma, Open Angle

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age40+

SponsorMinia University

About this trial

cyclodiode versus trabeculectomy with MMC in pseudophakic patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

1. Patients above 40 years old.

Disqualifiers

1. Patients with history of previous glaucoma surgery. 2. Patients who have used topical steroids within the last three months. 3. Patients with significant media opacity, such as corneal opacity, that obstructs fundoscopic examination.

Trial design

Design model

Parallel

Treatments tested in this trial

Trabeculectomy
Procedure/Surgery
Trabeculectomy with mitomycin c application
Slow coagulation trans-scleral cyclophotocoagulation
Procedure/Surgery
Slow coagulation trans-scleral cyclophotocoagulation

Treatment groups

50 Participants

are divided into 2 treatment groups

Group A: 25 patients will undergo trabeculectomy with MMC (group B).Active comparator 1 intervention

Group B: 25 patients will be subjected to SC-TSCPC (group A)Active comparator 1 intervention

Trial outcomes

Primary outcomes

evaluate and compare the amount of iop reduction between SC-TSCPC and trabeculectomy with MMC in the management of medically uncontrolled OAG in pseudophakic eyes.

measuring the IOP with Goldman applanation tonometer.

Time frame

6 months

evaluate and compare the degree of safety of SC-TSCPC versus trabeculectomy with MMC in the management of medically uncontrolled OAG in pseudophakic eyes.

if there is any inflammatory reaction, lost anterior chamber , cystoid macular edema

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Minia University

Lead sponsor

Source ClinicalTrials.gov

Apply now